Copyright
©The Author(s) 2016.
World J Radiol. Oct 28, 2016; 8(10): 829-845
Published online Oct 28, 2016. doi: 10.4329/wjr.v8.i10.829
Published online Oct 28, 2016. doi: 10.4329/wjr.v8.i10.829
Ref. | Year of pub | Tracer | Sensitivity | Specificity |
Lachter et al[8] | 2003 | 99mTc-HMPAO | 58% | 100% |
Kerry et al[10] | 2005 | |||
99mTc-HMPAO (2 h) | 99mTc-HMPAO | 87% | 86% | |
99mTc-Leukoscan (1 h) | 99mTc-Leukoscan | 20% | 86% | |
99mTc-Leukoscan (2 h) | 40% | 100% | ||
99mTc-Leukoscan (4 h) | 73% | 57% | ||
99mTc-Leukoscan (4 h-SPECT) | 87% | 57% | ||
Paredes et al[9] | 2010 | 99mTc-HMPAO | ||
Endoscopic recurrence | 88% | 42.9% | ||
Scintigraphic recurrence | 73.3% | 88.2% | ||
Aarntzen et al[19] | 2015 | 99mTc-CXCL8 | 95% | 44% |
- Citation: Caobelli F, Evangelista L, Quartuccio N, Familiari D, Altini C, Castello A, Cucinotta M, Di Dato R, Ferrari C, Kokomani A, Laghai I, Laudicella R, Migliari S, Orsini F, Pignata SA, Popescu C, Puta E, Ricci M, Seghezzi S, Sindoni A, Sollini M, Sturiale L, Svyridenka A, Vergura V, Alongi P, Young AIMN Working Group. Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art. World J Radiol 2016; 8(10): 829-845
- URL: https://www.wjgnet.com/1949-8470/full/v8/i10/829.htm
- DOI: https://dx.doi.org/10.4329/wjr.v8.i10.829